Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
基本信息
- 批准号:10401470
- 负责人:
- 金额:$ 25.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-17 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgonistAnimalsAssisted Reproductive TechnologyCalciumCationsCell membraneCell physiologyCellsClinicCompetenceContraceptive methodsCountryCouplesDataDetectionDevelopmentDiagnosisDivalent CationsElectrophysiology (science)EmbryoEmbryonic DevelopmentEndoplasmic ReticulumEventFamilyFertilityFertilizationGenesGenetic ModelsGenetic TranscriptionGerm CellsGoalsHealthHomeostasisHumanImageIn VitroInfertilityIon ChannelKnockout MiceKnowledgeLaboratoriesMammalsMediatingMethodsMissionModelingMolecularMusOocytesOutcomePathway interactionsPeriodicityPermeabilityPharmacologyPhosphotransferasesPhysiologicalPhysiologyPre-implantation Embryo DevelopmentProtocols documentationPublic HealthReagentRecoveryRegulationReportingReproductionResearchRoleSignal TransductionSystemTRP channelTestingTherapeuticTranscriptTranslatingUnited States National Institutes of HealthWomanantagonistbaseburden of illnessconditional knockouteggfemale fertilitygain of functionhuman diseaseimaging geneticsimprovedinfertility treatmentinhibitorinnovationinsightmembernovelnovel strategiesoocyte maturationoocyte qualitypregnantpreventreceptorreproductivereproductive successresponsezygote
项目摘要
There is a persistent gap in our knowledge of the molecules and mechanisms that mediate Ca2+ influx
into oocytes and eggs. Ca2+ influx is required for egg activation and embryo development in all mammals,
including human beings. This gap in our knowledge therefore represents a serious impediment, as until
it is filled we cannot physiologically modulate Ca2+ influx or objectively diagnose and treat infertility
associated with disturbances in Ca2+ homeostasis. The long-term goal is to understand how Ca2+
homeostasis is regulated in oocytes and eggs and identify its molecular effectors. The objective here is
to identify the Ca2+ channel(s) that mediate Ca2+ influx during maturation and fertilization and characterize
their regulatory mechanisms. Mouse oocytes/eggs are a great model because they display distinctive
Ca2+ entry during maturation and fertilization, and Ca2+ release is required for egg activation. The central
hypothesis is that expression and/or distinct regulation of underdetermined Ca2+ channels on the plasma
membrane underlies Ca2+ influx in oocytes, its inactivation during maturation and its recovery after
fertilization. This hypothesis was conceived based on extensive preliminary data. The rationale for this
research is that once the channels are identified, a better understanding of the molecular determinants
of oocyte maturation and fertilization will be gained. The findings here also have the potential to translate
into therapeutic methods to assist infertile couples in this country. We plan to test our central hypothesis
by pursuing the following specific aims: 1) Identify the Ca2+ channel(s) that mediate Ca2+ influx in oocytes
prior to and during maturation; and 2) Identify the Ca2+ influx channel(s) that support oscillations after
fertilization. Under Aim 1, Ca2+ imaging, pharmacology, conditional knockout mice, and electrophysiology
will be used to identify the active channel(s) and to assess the impact of Ca2+ influx on maturation; the
role of a TRPM7-like current recently discovered by the applicant and collaborators will be closely
examined. Under Aim 2, the signaling mechanism(s) whereby fertilization stimulates Ca2+ influx and the
contributing channel(s) will be determined. A novel approach that overcomes the inactivation of Ca2+
influx in eggs will facilitate these studies. Genetic models and electrophysiology will confirm the function
of these channel(s) during fertilization. The research in this application is innovative because it combines
electrophysiology, pharmacology and new KO lines, approach that has served to identify two new
channels in oocytes, including TRPM7, whose global deletion is embryonic lethal at E7.5. The
contribution of the proposed project is significant because it is expected to allow physiological modulation
of Ca2+ entry in oocytes and eggs that will produce new conditions and activation protocols for use in the
clinic. It will also expand our understanding of the impact of Ca2+ homeostasis on oocyte competence
and infertility.
我们对调节钙离子内流的分子和机制的了解一直存在空白。
变成卵母细胞和卵子。在所有哺乳动物中,卵子激活和胚胎发育都需要钙离子内流,
包括人类在内。因此,我们知识上的这种差距是一个严重的障碍,直到
它充满了我们无法从生理上调节钙离子内流或客观诊断和治疗不孕不育
与钙离子动态平衡失调有关。长期目标是了解钙离子是如何
动态平衡在卵母细胞和卵子中受到调节,并确定其分子效应器。这里的目标是
成熟受精过程中介导钙离子内流的钙通道(S)的鉴定及特性
他们的监管机制。小鼠卵母细胞/卵子是一个很好的模型,因为它们表现出独特的
卵子在成熟和受精过程中需要钙离子进入,而激活卵子需要钙离子的释放。中环
假说是血浆上钙离子通道的表达和/或明显的调节
卵母细胞膜是钙离子内流的基础,成熟过程中钙离子失活,成熟后恢复。
受精。这一假设是基于广泛的初步数据而提出的。这样做的理由是
研究表明,一旦确定了通道,就会更好地理解分子决定因素
将获得卵母细胞成熟和受精的可能性。这里的发现也有可能转化为
以治疗方法来帮助这个国家的不孕夫妇。我们计划测试我们的中心假设
通过追求以下具体目标:1)确定介导卵母细胞内钙内流的钙通道(S)
成熟前和成熟中;2)确定支持成熟后振荡的钙离子内流通道(S)
受精。在目标1下,钙离子成像、药理学、条件性基因敲除小鼠和电生理
将被用来识别活跃的通道(S),并评估钙离子内流对成熟的影响;
申请人和合作者最近发现的TRPM7类洋流的作用将密切相关
检查过了。在目标2下,受精刺激钙内流的信号机制(S)和
供稿渠道(S)将确定。一种克服钙离子失活的新方法
卵子的大量涌入将促进这些研究。遗传模型和电生理学将证实这一功能
这些通道(S)在受精过程中。这一应用的研究具有创新性,因为它结合了
电生理学、药理学和新的KO系,这一方法已用于识别两个新的
卵母细胞中的通道,包括TRPM7,其全局缺失在e7.5时是胚胎致死的。这个
拟议项目的贡献很大,因为预计它将允许生理调节
在卵母细胞和卵子中的钙离子进入将产生新的条件和激活方案用于
诊所。这也将扩大我们对钙离子稳态对卵母细胞能力的影响的理解。
和不孕不育。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multidrug resistance transporter-1 dysfunction perturbs meiosis and Ca2+ homeostasis in oocytes.
- DOI:10.1530/rep-22-0192
- 发表时间:2023-01-01
- 期刊:
- 影响因子:3.8
- 作者:Nabi, Dalileh;Bosi, Davide;Gupta, Neha;Thaker, Nidhi;Fissore, Rafael;Brayboy, Lynae M.
- 通讯作者:Brayboy, Lynae M.
SPERM FACTORS AND EGG ACTIVATION: ICSI and the discovery of the sperm factor and PLCZ1.
- DOI:10.1530/rep-21-0487
- 发表时间:2022-05-23
- 期刊:
- 影响因子:3.8
- 作者:Gupta, Neha;Akizawa, Hiroki;Lee, Hoi Chang;Fissore, Rafael A.
- 通讯作者:Fissore, Rafael A.
The eggstraordinary story of how life begins.
- DOI:10.1002/mrd.23083
- 发表时间:2019-01
- 期刊:
- 影响因子:2.5
- 作者:Parrington J;Arnoult C;Fissore RA
- 通讯作者:Fissore RA
Deletion of TRPV3 and CaV3.2 T-type channels in mice undermines fertility and Ca2+ homeostasis in oocytes and eggs.
小鼠 TRPV3 和 CaV3.2 T 型通道的缺失会破坏卵母细胞和卵子的生育能力和 Ca2 稳态。
- DOI:10.1242/jcs.257956
- 发表时间:2021
- 期刊:
- 影响因子:4
- 作者:Mehregan,Aujan;Ardestani,Goli;Akizawa,Hiroki;Carvacho,Ingrid;Fissore,Rafael
- 通讯作者:Fissore,Rafael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rafael Antonio Fissore其他文献
Rafael Antonio Fissore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rafael Antonio Fissore', 18)}}的其他基金
Mammalian Fertilization: Identifying the second sperm factor that induces residual calcium oscillations and its contributions to egg activation
哺乳动物受精:识别诱导残留钙振荡的第二个精子因子及其对卵子激活的贡献
- 批准号:
10574938 - 财政年份:2022
- 资助金额:
$ 25.33万 - 项目类别:
Regulation of Ca2+ influx in mouse oocytes and eggs during maturation and fertilization to improve assisted reproductive technologies and modulate fertility
调节小鼠卵母细胞和卵在成熟和受精过程中的 Ca2 流入,以改进辅助生殖技术并调节生育力
- 批准号:
9766344 - 财政年份:2018
- 资助金额:
$ 25.33万 - 项目类别:
Frontiers in Reproduction (FIR) Training Course
生殖前沿 (FIR) 培训课程
- 批准号:
10617172 - 财政年份:2014
- 资助金额:
$ 25.33万 - 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
- 批准号:
6687127 - 财政年份:2003
- 资助金额:
$ 25.33万 - 项目类别:
Release and molecular composition of mammalian SFs
哺乳动物 SF 的释放和分子组成
- 批准号:
6772484 - 财政年份:2003
- 资助金额:
$ 25.33万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:














{{item.name}}会员




